Innovative Oncology Program(s)

About Celon Pharma

Celon Pharma is a publicly traded, integrated pharmaceutical company based in Poland, with a strong focus on research and development. It employs over 160 scientists and leverages revenue from its generic drug portfolio to fund innovative drug discovery programs targeting cancers, neurological diseases, and metabolic disorders. The company's strategic direction includes partnerships, such as the collaboration with Tang Capital to establish Novohale Therapeutics, to advance its pipeline.

Therapeutic Areas